Diagnostikovat Hotel Spoušť acs med chem lett Darebák problém Pozvat
Readily Accessible High-Throughput Experimentation: A General Protocol for the Preparation of ChemBeads and EnzyBeads | ACS Medicinal Chemistry Letters
ACS Med Chem Lett (@ACSMedChemLett) / Twitter
Discovery and Optimization of Potent, Selective, and in Vivo Efficacious 2-Aryl Benzimidazole BCATm Inhibitors | ACS Medicinal Chemistry Letters
Design, Synthesis, and Anti-HBV Activity of New Bis(l-amino acid) Ester Tenofovir Prodrugs | ACS Medicinal Chemistry Letters
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters | ACS Medicinal Chemistry Letters
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Orally Bioavailable and Brain Penetrant Mutant IDH1 Inhibitors | ACS Medicinal Chemistry Letters
Discovery and Development of Cyclic Peptide Inhibitors of CIB1 | ACS Medicinal Chemistry Letters
Featured Letter in ACS Medicinal Chemistry Letters – NITSCHE LAB
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation | ACS Medicinal Chemistry Letters
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion | ACS Medicinal Chemistry Letters
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists | ACS Medicinal Chemistry Letters
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice | ACS Medicinal Chemistry Letters
Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy | ACS Medicinal Chemistry Letters
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery | ACS Medicinal Chemistry Letters
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series | ACS Medicinal Chemistry Letters
Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines | ACS Medicinal Chemistry Letters
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands | ACS Medicinal Chemistry Letters
Identification and Structure-Guided Development of Pyrimidinone Based USP7 Inhibitors | ACS Medicinal Chemistry Letters
Discovery of N-(1-Acryloylazetidin-3-yl)-2-(1H-indol-1-yl)acetamides as Covalent Inhibitors of KRASG12C | ACS Medicinal Chemistry Letters
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family | ACS Medicinal Chemistry Letters
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors | ACS Medicinal Chemistry Letters